Both protein-energy malnutrition (PEM) and obesity represent major challenges for paediatric nutrition. The aim of this review is to summarise available data regarding the effect of PEM and obesity on the availability of essential-and long-chain polyunsaturated fatty acids (LC-PUFAs) in childhood.
Introduction
Both protein-energy malnutrition (PEM) and obesity represent major challenges for paediatrics.
Many millions of children living in developing countries and in socioeconomically underprivileged regions of some industrial countries suffer from chronic PEM. Moreover, the spread of human immunode®ciency virus infection has recently resulted in the reappearance of childhood PEM in populations where this condition has been effectively prevented for many decades. Malnourished children are prone to infectious diseases that have a major contribution to childhood morbidity and mortality.
The prevalence of childhood obesity is up to 15±20% in the majority of af¯uent countries, and obese children can be found in certain subsets of the populations of many developing countries. Though childhood obesity has only limited impact on morbidity in the paediatric age-group, the late cardiovascular and metabolic consequences of being overweight as a child are closely connected to long-term morbidity and mortality (Must et al, 1992) .
One of the pertinent clinical features of PEM is reduction of body fat stores, whereas pronounced obesity is characterised by abnormal expansion of adipose tissues. Body fat predominantly consists of triacylglycerols and the fatty acids contained in the adipocytes can be liberated into or taken up from the circulating plasma lipid pool. It may be of clinical relevance if the quantitative changes of body fat contents were also accompanied by altered fatty acid composition of plasma lipids, since these lipids serve as substrates for metabolism and deposition in other tissues.
The aim of the present review is to summarise current data regarding the effect of PEM and obesity on the availability of essential-and long-chain polyunsaturated fatty acids in childhood.
Functional role of long-chain metabolites of essential fatty acids
The nutrition essentiality of linoleate (C18: 2n-6, LA) and alpha-linolenate (C18: 3n-3, ALA) has been known for about 70 and 15 y, respectively (Burr & Burr, 1930; Holman et al, 1982) . The classical symptoms of essential fatty acid (EFA) de®ciency (for example, scaly dermatitis and brittle nails) were described in patients on fat free diets and EFA supplementation alone was able to ameliorate the symptoms. The possibility that not only LA and ALA but also their long-chain polyunsaturated fatty acid (LC-PUFA) metabolites should be regarded as conditionally essential nutrients has recently been put forward on the basis of developmental differences observed between preterm as well as term infants fed with or without preformed dietary LC-PUFA (comprehensively reviewed by Bendich & Brock, 1997) .
So far four LC-PUFAs, namely dihomo-gamma-linolenate (C20: 3n-6) and arachidonate (C20: 4n-6, AA) from the n-6 and eicosapentaenoate (C20: 5n-3) and docosahexaenoate (C22: 6n-3, DHA) from the n-3 series were attributed speci®c biological functions.
Low AA values have been associated with reduced linear growth in the perinatal period (Koletzko & Braun, 1991; Leaf et al, 1992; Carlson et al, 1993) . Though data obtained in investigations on perinatal growth cannot be directly extrapolated to growth in general, the observation that reduced availability of AA appears to affect growth in one period of life suggests that physiological availability of AA might be important for growth during other periods of childhood as well.
In discussions about the possible untoward functional consequences of low availability of DHA, the role of DHA in retinal and brain maturation is emphasised (Uauy et al, 1992) . However, DHA-containing phospholipids play also an important role as structural elements of several membrane enzymes, receptors and other proteins in both peroxisomes and other subcellular organelles. Functions like insulin receptor binding or muscle calcium transport has been reported to be in¯uenced by reduced contribution of DHA to structural cellular lipids (biochemical data have been recently reviewed by Infante & Huszagh, 1997) .
Dihomo-gamma-linolenate (C20: 3n-6), AA and eicosapentaenoate (C20: 5n-3) play delicate and partly antagonistic metabolic roles (Horrobin, 1992; Needleman et al, 1986; Simopoulos, 1991) as precursors of various prostaglandins, thromboxanes and leukotrienes. Imbalance in the availability of these three LC-PUFAs for eicosanoid synthesis was suggested to contribute to clinical symptoms in various pathologic conditions which are common also in childhood, like pain and in¯ammation (Davies et al, 1984) , immunode®ciencies (Kinsella et al, 1990) , cystic ®brosis (Christophe & Robberecht, 1996) , chronic renal failure (Peck, 1997) , and chronic liver disease (Cabre Â et al, 1996) . Prostaglandins and thromboxanes are also involved in atherogenesis (Ross, 1993) and it cannot be excluded that altered availability of eicosanoid precursors in overnutrition (vide infra) may be an additional factor that predispose obese subjects to the development of atherosclerotic lesions.
The above-discussed speci®c metabolic roles of LC-PUFA metabolites of LA and ALA suggest that abnormal availability of the LC-PUFA metabolites may exert untoward effect on various metabolic processes. The need for LC-PUFA metabolites can either be met by endogenous synthesis from EFAs or by dietary uptake of preformed LCPUFAs. If physiological availability of LC-PUFAs is to be maintained, altered activity of the bioconversion of EFAs to LC-PUFAs should be compensated by modi®ed dietary intakes of EFAs or LC-PUFAs.
Novel biochemical aspects of essential fatty acid metabolism
The bioconversion of LA to AA and ALA to DHA consist of subsequent desaturation and chain-elongation steps. Recent data obtained both by in vitro experiments and in human studies indicate that the enzymatic pathways for the bioconversion of EFAs to their corresponding LC-PUFA metabolites may be more complex than traditionally depicted. In order to provide a basis for a more detailed discussion of the availability of n-6 and n-3 polyunsaturated fatty acids in PEM and obesity, we give a brief overview of the recent developments in the biochemistry of EFA metabolism.
The enzymatic conversion of LA to AA is shown on Figure 1 . Traditional (right panel) and alternative (left panel) concepts of the enzymatic pathway of the conversion of ALA to DHA are shown on Figure 2 . The ®rst three enzymatic steps (C18: 3n-3 A C18: 4n-3 A C20: 4n-3 A C20: 5n-3) are common in both concepts and require the same enzymes as n-6 LC-PUFA synthesis. According to the traditional concept, eicosapentaenoate (C20: 5n-3) is elongated to docosapentaenoate (C22: 5n-3) and then a delta-4-desaturase enzyme catalyses the conversion of this fatty acid to the principal n-3 LC-PUFA, DHA.
However, no biochemical evidence of the existence of a delta-4-desaturase enzyme has been presented so far. In contrast, data from animal (Voss et al, 1991; Mohammed et al, 1995) and human tissue culture (Rosenthal et al, 1991) studies as well as recent human observations with stable isotope techniques (Sauerwald et al, 1997) unequivocally demonstrated the existence of the suggested intermediary metabolites of the alternative pathway, tetracosapentaenoate (C24: 5n-3) and tetracosahexaenoate (C24: 6n-3). Twenty-four hours after the oral administration of 13 Clabelled ALA, isotope enrichment in tetracosapentaenoate and tetracosahexaenoate in plasma phospholipids of term and preterm infants was more than four-times higher than in DHA (Sauerwald et al, 1997) . The proposed involvement of peroxisomal beta-oxidation in DHA synthesis is further supported by the markedly reduced availability of DHA in patients with de®cient peroxisomal function (Martinez et al, 1995) . The quantitative contribution of the alternative pathway to DHA synthesis remains to be clari®ed.
Metabolism of essential fatty acids in malnourished children
Reduced contribution of certain EFA and LC-PUFA metabolites to the fatty acid composition of various plasma and erythrocyte membrane lipids is a consistent ®nding in investigations on the fatty acid status of children with PEM (Holman et Figure 1 Enzymatic conversion of linoleate (C18: 2n-6) to arachidonate (C20: 4n-6). Symbols: (1) delta-6-desaturation, (2) elongation, (3) delta-8-desaturation, (4) delta-5-desaturation.
Essential fatty acid metabolism in childhood T Decsi et al LC-PUFA de®ciency in severe PEM has been unequivocally clari®ed so far. Signi®cantly lower LA and AA values in malnourished children than in controls is a uniform ®nding in most studies, whereas plasma and erythrocyte membrane ALA values appear to be basically unaffected by PEM (Holman et al, 1981; Wolff et al, 1984; Koletzko et al, 1986; Vajreswari et al, 1990; Leichsenring et al, 1992) . It is unclear whether the availability of DHA is affected: signi®cantly lower plasma phospholipid DHA values than in healthy controls were reported in Argentine (Holman et al, 1981) and Nigerian (Leichsenring et al, 1995) but not in another group of Nigerian (Koletzko et al, 1986) and in Sudanese (Leichsenring et al, 1992 ) malnourished children (Table 1) .
Since n-6 and n-3 EFAs and EFA metabolites compete for the same enzymatic pathway of AA and DHA synthesis and n-6 and n-3 LC-PUFAs (AA, dihomo-gamma-linolenate and eicosapentaenoate) compete for the same enzymes of eicosanoid synthesis, it is of great practical importance whether n-6 LC-PUFA de®ciency alone or in combination with reduced availability of n-3 LC-PUFA should be anticipated in children with PEM. To complicate matters, different effects on EFA metabolism of the two major forms of PEM, kwashiorkor and marasmus were reported in some (Vajreswari et al, 1990) but not in other (Koletzko et al, 1986) studies. (Vajreswari et al, 1990 reported subnormally low erythrocyte membrane lipid AA values in marasmic children, but not in children suffering from kwashiorkor.)
Reduced availability of AA (and probably DHA) in children with PEM may be the consequence of three distinct pathogenic factors (or a combination of these three factors): (1) reduced intake of the precursor EFAs; (2) impaired conversion of the EFAs to their respective LC-PUFA metabolites; and (3) increased LC-PUFA turnover (for eicosanoid synthesis, beta-oxidation or peroxidative degradation). The different pathomechanisms may require different therapeutical approaches: increase of EFA supply, enhancement of dietary supply of preformed LC-PUFA and increase of lipid-soluble antioxidant intake. Since further investigations are clearly needed to answer the above questions, we set out to study the composition of plasma phospholipids in severely malnourished children and in age-matched, healthy controls (Decsi et al, 1995) .
The malnourished children (n 35) were investigated in an orphanage in Rumania as part of a humanitarian collaboration between the government of Tyrol, Austria and the local authorities [details of the collaboration and epidemiological ®ndings were published elsewhere (Zaknun et al, 1991) ]. Physical examination and anthropometric measurements were carried out and venous blood samples were collected. Fatty acid composition of plasma phospholipids was determined with high-resolution capillary gas-liquid chromatography (Decsi et al, 1995) and compared with the fatty acid composition of plasma phospholipids in healthy and well-nourished, age-matched German children (n 25) (Decsi & Koletzko, 1994) . Results are presented as medians (interquartile ranges), because some fatty acid data showed skewed distributions. Mann±Whitney's two-sided rank test was used for intergroup comparison of fatty acid pro®les. Differences were regarded as statistically signi®-cant at P`0.05.
The body weights of all the malnourished children were at or under the third centile for age. These children were most severely malnourished, with body weights and heights of 9.2 (2.1) kg and 72.0 (5.5) cm at ages of 29 (7) months.
Plasma phospholipid LA, dihomo-gamma-linolenate (C20: 3n-6) and AA values of malnourished children are compared to those of the controls on (1) delta-6-desaturation, (2) elongation, (3) delta-8-desaturation, (4) delta-5-desaturation, (5) delta-7-desaturation, (6) delta-4-desaturation, (7) peroxisomal beta-oxidation. Symbols: n number of malnourished children in the study, LA linoleate (C18: 2n-6), AA arachidonate (C20: 4n-6), ALA alpha-linolenate (C18: 3n-3), DHA docosahexaenoate (C22: 6n-3), ; signi®cantly (P`0.01) lower in malnourished than in controls, n.s. not different from controls, n.r. not reported.
Essential fatty acid metabolism in childhood T Decsi et al re¯ecting delta-6-desaturase enzyme activity [(C18: 3n-6 C20: 3n-6)/C18: 2n-6] did not differ between the two groups, whereas the product/substrate ratios re¯ecting the activity of delta-5-desaturation (C20: 4n-6/C20: 3n-6) were signi®cantly lower in malnourished than in well-nourished children [2.14 (0.29) vs 2.85 (0.36), P`0.005]. Plasma phospholipid ALA values did not differ between the two groups ( Figure 4 ). Children with PEM showed signi®cantly higher phospholipid eicosapentaenoate (C20: 5n-3) values than the controls [0.27 (0.08) vs 0.10 (0.21), P`0.01]. In contrast both docosapentaenoate (C22: 5n-3) and DHA values were signi®cantly lower in malnourished than in well-nourished children (Figure 4) .
Both total n-6 and n-3 LC-PUFA values were signi®-cantly lower in children with PEM than in controls [7.05 (0.73) vs 8.70 (0.82) and 1.94 (0.26) vs 4.37 (1.02), respectively, P`0.005], whereas the n-6/n-3 LC-PUFA ratios were signi®cantly higher in malnourished than in well-nourished subjects [5.98 (0.37) vs 2.75 (0.73), P`0.0005]. Values of eicosatrienoate (C20: 3n-9, Mead acid)Ða traditional indicator of n-6 and n-3 EFA de®-ciencyÐdid not differ between the two groups.
Linear correlation coef®cients for relation between body weight and age and for that of AA, ALA, DHA and LA values are shown in Table 2 . Age was not related to EFA or LC-PUFA values. There were no correlations between body weight and plasma phospholipid ALA and LA values. In contrast, body weights were signi®cantly and positively related to the percentage contributions of both AA and DHA.
The data obtained in the study reviewed here do not support the assumption that reduced availability of LC-PUFA in malnourished children is to be primarily attributed to decreased EFA supply. Both AA and DHA values were signi®cantly lower in malnourished than in well-nourished children, while only LA but not ALA values differed between the two groups. Nutritional status (as re¯ected by body weights) was positively related to LC-PUFA but not to EFA values. Furthermore, contribution of major intermediary metabolites of both n-6 and n-3 EFA metabolism (dihomo-gamma-linolenate and eicosapentaenoate, respectively) were not lower but signi®cantly higher in malnourished than in control subjects.
The n-6 polyunsaturated fatty acid pattern seen in this study is compatible with an impairment of delta-5-desaturation in children with PEM. The chain elongation steps in EFA metabolism appear to be largely independent of hormonal in¯uences (Brenner, 1981; Brenner, 1991) and regulated primarily by substrate availability. Substrate availability on its own can hardly explain the simultaneous presence of signi®cantly lower LA and higher eicosadienoate values in malnourished than in control children. However, retroconversion (that is saturation) of dihomogamma-linolenate to eicosadienoate (C20: 3n-6 A C20: 2n-6) may explain the apparent controversy and can be regarded as a likely event if reduced conversion of dihomo-gamma-linolenate to AA (C20: 3n-6 A C20: 4n-6) is assumed.
The more complex biosynthesis of DHA from ALA together with the technical dif®culties of measuring lower concentrated intermediary metabolites (C18: 4n-3, C20: 3n-3 and C20: 4n-3) of the n-3 synthetic pathway render interpretation of n-3 LC-PUFA data less unequivocal than the evaluation of n-6 LC-PUFA values. Reduced delta-5-desaturation on its own cannot explain the n-3 fatty acid pattern seen in children with PEM in this study, since values of eicosapentaenoate (C20: 5n-3) were not lower but signi®cantly higher in malnourished children than in the controls, and this LC-PUFA is after the delta-5-desaturation Figure 4 Percentage contributions of alpha-linolenate (C18: 3n-3), docosapentaenoate (C22: 5n-3) and docosahexaenoate (C22: 6n-3) to the fatty acid composition of plasma phospholipids in children suffering from protein-energy malnutrition (PEM, n 35) and in age-matched, healthy controls (n 25). IQR denotes interquartile range. Adapted from Decsi et al, 1995 . Figure 3 Percentage contributions of linoleate (C18: 2n-6), dihomogamma-linolenate (C20: 3n-6) and arachidonate (C20: 4n-6) to the fatty acid composition of plasma phospholipids in children suffering from protein-energy malnutrition (PEM, n 35) and in age-matched, healthy controls (n 25). IQR denotes interquartile range. Adapted from Decsi et al, 1995. Several steps in the conversion of eicosapentaenoate to DHA may be affected by PEM. Delta-6-desaturase activity re¯ected by the (C18: 3n-6 C20: 3n-6)/C18: 2n-6 ratio did not differ between the two groups in this study. However, the existence of two different delta-6-desaturase activities has been recently reported in one study on human Y-79 retinoblastoma cells and Jurkat T cells (Marzo et al, 1996) , therefore it is unsure whether the (C18: 3n-6 C20: 3n-6)/ C18: 2n-6 product/substrate ratio also reliably re¯ects the delta-6-desaturation of tetracosapentaenoate (C24: 5n-3) to tetracosahexaenoate (C24: 6n-3). In animal experiments, delta-6-desaturase is stimulated by protein and energy intakes (De Tomas et al, 1980; Brenner, 1991) , therefore it appears to be conceivable to associate PEM with reduced delta-6-desaturase activity. Alternatively, chain-shortening of tetracosahexaenoate (C24: 6n-3) to DHA requires not only beta-oxidation per se but previous transport from the mitochondria to the peroxisomes and subsequent esteri®ca-tion of DHA for the incorporation into structural lipids (Baykousheva et al, 1995) . Impairment of the complex mechanism of conversion of tetracosahexaenoate to DHA may also explain the n-3 LC-PUFA pattern seen in the present study. Anyhow, decreased conversion of docosapentaenoate to DHA may lead to its enhanced retroconversion to eicosapentaenoate (Voss et al, 1991) , explaining thereby the higher eicosapentaenoate values in malnourished than in well-nourished children in this study.
Summing up, children with severe PEM showed reduced plasma phospholipid AA and DHA values both in our own study reviewed here and in other studies reported in the literature. In our study, the extent of AA and DHA de®ciency was directly proportional to the extent of undernutrition and the n-6 and n-3 fatty acid patterns suggested that reduced contribution of AA and DHA to plasma fatty acid composition was a consequence of impaired bioconversion of LA and ALA to their respective LC-PUFA metabolites rather than of de®cient EFA supply on its own. We speculate that severely malnourished children may bene®t from enhanced dietary supply of both n-6 and n-3 LC-PUFA.
Metabolism of essential fatty acids in obese children
Restriction of dietary fat intakes is a cornerstone of the treatment of overweight and the possibility arises that decrease of fatty acid supply (including EFAs) may jeopardise the physiological availability of LC-PUFA metabolites in obese subjects on low fat diets. In order to optimise the fat blends of low-energy diets, fatty acid composition of plasma lipid classes was investigated in obese adults on various weight reduction diets (Ro Èssner et al, 1989; Gray et al, 1991; Phinney et al, 1991; Christophe et al, 1992) . The data obtained are, however, somewhat controversial. Successful weight reduction was associated with increased contribution of AA to plasma fatty acid composition in these studies, suggesting thereby that the availability of AA in obese subjects prior to the treatment of overweight might have been lower than that characteristic to the normally nourished population.
Indeed, Phinney et al (1991) found lower percentage contribution of AA to plasma phospholipids in untreated obese adults on omnivorous diet than in control subjects, and suggested that weight reduction diets should be supplemented with AA. However, Ro Èssner et al (1991) reported signi®cantly higher AA values in plasma cholesterol esters in non-dieting obese adults than in controls. Data obtained in genetically obese animals are also equivocal. Contributions of AA to plasma and tissue phospholipid fatty acids were lower in obese Zucker rats (fa/fa) than in lean (fa/-) animals (Guesnet et al, 1990) . In contrast, increased conversion of LA to AA was reported in obese mice (Cunnane et al, 1985a) . Hence, so far neither animal data nor human observations elucidated the dietary role of EFAs and/or LC-PUFAs in weight reduction diets.
The question whether to supply or not EFAs or LCPUFAs to weight reduction diets tailored for childhood obesity deserves special attention since many obese children embark on dietary treatment in parallel with the peripubertal growth spurt. If obese children have reduced LC-PUFA status prior to dietary interventionÐas reported for obese adults (Phinney et al, 1991) Ðdietary supplementation may be necessary to maintain physiological availability of LC-PUFAs for growth. However, supplementation of low fat diets with EFAs or their LC-PUFA metabolites may lead to untoward effects as well. Polyunsaturated fatty acids are prone to lipid peroxidation and their abundance may contribute to the increased risk of atherogenesis in obese subjects. Moreover, supplementation of further dietary components to low energy diets would certainly increase costs and may decrease compliance to the diet. In order to determine EFA and LC-PUFA status in obese children prior to dietary intervention, we investigated the fatty acid composition of plasma lipid classes in non-dieting obese teenagers (Decsi et al, 1996a) .
The obese children (n 22) were referred to the Outpatient Division of Obesity and Related Metabolic Disorders of the Department of Paediatrics, University Medical School of Pe Âcs, Pe Âcs, Hungary because of their overweight. Anthropometric data were obtained and fasting venous blood samples were taken. Plasma cholesterol, glucose, immunoreactive insulin and triacylglycerol concentrations in the obese children were measured with routine laboratory methods. Fatty acid composition of plasma phospholipids, triacylglycerols and cholesterol esters was determined by high-resolution capillary gas-liquid chromatography (Decsi et al, 1996a ) and compared to the corresponding fatty acid data of normally nourished, age-matched controls (n 25) (Decsi & Koletzko, 1994 ). This control group was different from that investigated in the study on malnourished children.
Body weights of the obese children were 89.0 AE 20.8 kg at the age of 13.7 AE 1.4 y (mean AE s.d.). The extent of overweight expressed as a percentage of ideal body weight for age, gender and height ranged 31±131%, body mass indices were 32.9 AE 5.2 kg/m 2 and body fat contents were 39.1 AE 5.4%. Average plasma cholesterol concentrations in the obese children were normal (4.24 AE 0.24 mmol/ l), whereas plasma triacylglycerol concentrations were slightly elevated (1.64 AE 0.70 mmol/l). The average value of fasting plasma immunoreactive insulin concentrations in the obese children was high (19.4 AE 8.0 mU/ml) and exceeded the mean plus 2 s.d. value for normal children (20 mU/ml) in nine subjects (range: 21±39 mU/ml), in spite of plasma glucose concentrations not exceeding 5.0 mmol/l.
Plasma phospholipid LA, dihomo-gamma-linolenate (C20: 3n-6) and AA values in obese children are compared to those of the controls on Figure 5 . LA values did not differ between the two groups, whereas the contributions of Essential fatty acid metabolism in childhood T Decsi et al both dihomo-gamma-linolenate and AA to plasma phospholipid fatty acids were signi®cantly higher in obese children than in the normally nourished controls. In contrast, plasma phospholipid eicosadienoate (C20: 2n-6) values did not differ between obese children and controls [0.39 (0.06) vs 0.37 (0.04), not signi®cant]. The differences between obese subjects and controls in n-6 polyunsaturated fatty acid pro®les in plasma triacylglycerols and cholesterol esters (data not shown) were similar to those seen in plasma phospholipids.
Plasma phospholipid ALA and DHA values did not differ between the two groups ( Figure 6 ). Percentage contributions of ALA to the composition of plasma triacylglycerol and cholesterol ester fatty acids were signi®-cantly lower in obese children than in non-obese controls [0.26 (0.06) Product/substrate ratios of n-6 LC-PUFA biosynthesis in plasma lipid classes of obese children and age-matched controls are compared in Table 3 . The product/substrate ratios re¯ecting delta-6-desaturase enzyme activity [(C18: 3n-6 C20: 3-n6)/C18: 2n-6] were signi®cantly higher in both phospholipids and cholesterol esters in obese subjects than in controls. In contrast, the ratios re¯ecting the activity of delta-5-desaturation (C20: 4n-6/ C20: 3n-6) were signi®cantly lower in triacylglycerols of obese children than in controls, whereas no differences in phospholipids and cholesterol esters were seen.
The major ®nding of the study reviewed here was markedly elevated n-6 LC-PUFA values in plasma lipids of obese children compared to age-matched non-obese controls. Theoretically, there are at least ®ve different factors that may contribute to the enhancement of plasma n-6 LC-PUFA values in an obese individual: (1) a high dietary intake of the precursor fatty acid LA; (2) enhanced rate of the synthesis of n-6 LC-PUFA from LA; (3) a high dietary intake of preformed n-6 LC-PUFA; (4) diminished rate of n-6 LC-PUFA clearance from the circulation (decreased rate of incorporation into tissues or of eicosanoid synthesis or of beta-oxidation); and (5) liberation of stored n-6 LC-PUFA from adipose tissues.
Some of these possibilities seem to be unlikely explanations for the high n-6 LC-PUFA values observed in the obese children. High dietary intake of LA should have resulted in high contribution of LA to plasma lipids but plasma LA values did not differ between obese children and controls. There are few foods in which AA constitutes more than 2±6% of total fatty acid contents (egg yolk, beef liver, mackerel, whale oils) and these foods do not contribute substantially to the self-selected diet of young teenagers. We are unaware of known pathophysiological mechanism that would lead to decreased n-6 LC-PUFA utilisation in non-dieting obese teenagers. Increased liberation of stored n-6 LC-PUFA from adipose tissues may explain enhancement of plasma AA values following successful weight reduction in obese subjects Ð as it has been shown in obese adults (Ro Èssner et al, 1989; Gray et al, 1991; Phinney et al, 1991; Christophe et al, 1992 ) Ð but not in untreated obesity.
The fatty acid patterns seen in the obese children in this study were, however, consistent with an enhanced Figure 6 Percentage contributions of alpha-linolenate (C18: 3n-3), docosapentaenoate (C22: 5n-3) and docosahexaenoate (C22: 6n-3) to the fatty acid composition of plasma phospholipids in obese children (n 22) and in age-matched, healthy controls (n 25). IQR, n.d. and n.s. denote interquartile range, not detectable and not signi®cant, respectively. Adapted from Decsi et al, 1996a . Figure 5 Percentage contributions of linoleate (C18: 2n-6), dihomogamma-linolenate (C20: 3n-6) and arachidonate (C20: 4n-6) to the fatty acid composition of plasma phospholipids in obese children (n 22) and in age-matched, healthy controls (n 25). IQR and n.s. denote interquartile range and not signi®cant, respectively. Adapted from Decsi et al, 1996a. Essential fatty acid metabolism in childhood T Decsi et al conversion of LA to its LC-PUFA metabolites. In spite of the similar LA values, percentage contributions of dihomogamma-linolenate (C20: 3n-6) and AA were signi®cantly higher in obese children than in the controls. The similar eicosadienoate (C20: 2n-6) values seen in the two groups further support the concept that chain-elongation was unaffected but desaturase activity was enhanced in the obese children. The product/substrate ratios were indicative of increased delta-6-desaturase activity in the obese children, whereas those re¯ecting delta-5-desaturation were similar or even lower in the obese children than in the non-obese controls. Enhancement of protein and energy intakes has been reported to stimulate delta-6-desaturase activity in animal experiments (De Tomas et al, 1980) . This effect may be at least partly mediated by insulin, since the availability of insulin has been positively associated to the activity of delta-6-desaturation (Mercuri et al, 1967; Holman et al, 1983; Huang et al, 1984) and enhanced nutrient intakes obviously stimulate insulin secretion. Plasma insulin concentrations increase with the duration of obesity in children with negative family history for diabetes mellitus and re¯ects impaired glucose tolerance (Molna Âr, 1990) . Insulin sensitivity assessed by euglycaemic clamp studies in healthy humans was found to be positively related to the percentage contributions of AA to phospholipid fatty acids in both plasma (Pelika Ânova Â et al, 1989) and skeletal muscle (Borkman et al, 1993) .
These considerations may give rise to the speculation that with increasing duration of obesity and, consequently, decreasing tissue insulin sensitivity the effect of insulin to stimulate LC-PUFA synthesis becomes insuf®cient to compensate for other mechanism that decrease the availability of LC-PUFA. There are at least two factors that are closely related to the extent and/or duration of obesity and may be inversely associated with plasma LC-PUFA values. Hyperlipidaemia is a common ®nding in chronic obesity and hypertriacylglycerolaemia was inversely related to plasma AA values both in the study reviewed here (Decsi et al, 1996a) and in animal studies in rats, hamsters, guinea pigs and monkeys (Cunnane et al, 1985b) . Polyunsaturated fatty acids are prone to lipid peroxidation and fasting plasma insulin concentrations were found to be inversely related to the availability of the most important lipid-soluble antioxidant, alpha-tocopherol in obese children (Decsi et al, 1996b) .
We conclude that obese children do not appear to require EFA or LC-PUFA supplementation to low fat diets. However, increased availability of LC-PUFA in plasma lipid classes may stimulate lipid peroxidation and contribute to atherogenesis in obese children. Indeed, recently we found reduced availability of the major lipidsoluble antioxidants alpha-tocopherol and beta-carotene in obese children compared to age-matched non-obese controls (Decsi et al, 1997) . It requires further research to delineate whether high concentrations of LC-PUFA combined with reduced availability of lipid soluble antioxidants may be one of the many factors predisposing obese children to a high risk for the development of atherosclerosis later in life.
